Moitra Subhabrata, Carsin Anne-Elie, Abramson Michael J, Accordini Simone, Amaral Andre F S, Anto Josep, Bono Roberto, Casas Ruiz Lidia, Cerveri Isa, Chatzi Leda, Demoly Pascal, Dorado-Arenas Sandra, Forsberg Bertil, Gilliland Frank, Gislason Thorarinn, Gullón Jose A, Heinrich Joachim, Holm Mathias, Janson Christer, Jogi Rain, Gómez Real Francisco, Jarvis Debbie, Leynaert Bénédicte, Nowak Dennis, Probst-Hensch Nicole, Sánchez-Ramos José Luis, Raherison-Semjen Chantal, Siroux Valerie, Guerra Stefano, Kogevinas Manolis, Garcia-Aymerich Judith
Division of Pulmonary Medicine, Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, Alberta, Canada
Non-Communicable Diseases and Environment Programme, ISGlobal, Barcelona, Spain.
Thorax. 2023 Feb;78(2):128-135. doi: 10.1136/thoraxjnl-2021-217867. Epub 2022 Apr 27.
Obesity is a known risk factor for asthma. Although some evidence showed asthma causing obesity in children, the link between asthma and obesity has not been investigated in adults.
We used data from the European Community Respiratory Health Survey (ECRHS), a cohort study in 11 European countries and Australia in 3 waves between 1990 and 2014, at intervals of approximately 10 years. We considered two study periods: from ECRHS I () to ECRHS II (), and from ECRHS II () to ECRHS III (). We excluded obese (body mass index≥30 kg/m) individuals at visit . The relative risk (RR) of obesity at associated with asthma at was estimated by multivariable modified Poisson regression (lag) with repeated measurements. Additionally, we examined the association of atopy and asthma medication on the development of obesity.
We included 7576 participants in the period ECRHS I-II (51.5% female, mean (SD) age of 34 (7) years) and 4976 in ECRHS II-III (51.3% female, 42 (8) years). 9% of participants became obese in ECRHS I-II and 15% in ECRHS II-III. The risk of developing obesity was higher among asthmatics than non-asthmatics (RR 1.22, 95% CI 1.07 to 1.38), and particularly higher among non-atopic than atopic (1.47; 1.17 to 1.86 vs 1.04; 0.86 to 1.27), those with longer disease duration (1.32; 1.10 to 1.59 in >20 years vs 1.12; 0.87 to 1.43 in ≤20 years) and those on oral corticosteroids (1.99; 1.26 to 3.15 vs 1.15; 1.03 to 1.28). Physical activity was not a mediator of this association.
This is the first study showing that adult asthmatics have a higher risk of developing obesity than non-asthmatics, particularly those non-atopic, of longer disease duration or on oral corticosteroids.
肥胖是已知的哮喘风险因素。尽管有证据表明哮喘会导致儿童肥胖,但哮喘与肥胖之间的联系在成年人中尚未得到研究。
我们使用了欧洲共同体呼吸健康调查(ECRHS)的数据,这是一项在1990年至2014年期间分三波在11个欧洲国家和澳大利亚进行的队列研究,间隔约为10年。我们考虑了两个研究时期:从ECRHS I()到ECRHS II(),以及从ECRHS II()到ECRHS III()。我们排除了在访视时肥胖(体重指数≥30 kg/m)的个体。通过多变量修正泊松回归(滞后)和重复测量来估计在时与哮喘相关的肥胖相对风险(RR)。此外,我们研究了特应性和哮喘药物治疗与肥胖发生之间的关联。
我们纳入了ECRHS I-II期间的7576名参与者(女性占51.5%,平均(标准差)年龄为34(7)岁)和ECRHS II-III期间的4976名参与者(女性占51.3%,42(8)岁)。在ECRHS I-II期间,9%的参与者变得肥胖,在ECRHS II-III期间为15%。哮喘患者发生肥胖的风险高于非哮喘患者(RR 1.22,95%置信区间1.07至1.38),尤其是非特应性患者比特应性患者更高(1.47;1.17至1.86对比1.04;0.86至1.27),疾病持续时间较长的患者(病程>20年时为1.32;1.10至1.59,病程≤20年时为1.12;0.87至1.43)以及使用口服糖皮质激素的患者(1.99;1.26至3.15对比1.15;1.03至1.28)。身体活动不是这种关联的中介因素。
这是第一项表明成年哮喘患者比非哮喘患者发生肥胖风险更高的研究,尤其是那些非特应性、疾病持续时间较长或使用口服糖皮质激素的患者。